Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-057718
Filing Date
2022-05-09
Accepted
2022-05-09 19:07:44
Documents
2
Period of Report
2022-04-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2214951-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2214951-1_3seq1.xml 3 2722
2 EXHIBIT 24 tm2214951d1_ex24.htm EX-24 8400
  Complete submission text file 0001104659-22-057718.txt   12501
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Issuer) CIK: 0001868912 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 7372 Services-Prepackaged Software

Mailing Address C/O ENFUSION, INC. 125 SOUTH CLARK STREET SUITE 750 CHICAGO IL 60603
Business Address
Bastone Bronwen (Reporting) CIK: 0001927636 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40949 | Film No.: 22906751